The cardiac "sympathetic afferent" reflex (CSAR) has been reported to increase sympathetic outflow and depress baroreflex function via a central Angiotensin II (Ang II) mechanism. In the present study, we examined the role of AT 1 receptors in the nucleus tractus solitarius (NTS) in mediating the interaction between the CSAR and the baroreflex in anesthetized rats. We examined the effects of bilateral microinjection of AT 1 receptor antagonist losartan (100 pmol) into the NTS on baroreflex control of renal sympathetic nerve activity (RSNA) before and after CSAR activation by epicardial application of capsaicin (0.4 µg). Using single-unit extracellular recording, we further examined the effects of CSAR activation on the barosensitivity of barosensitive NTS neurons and the effects of intravenous losartan (2 mg/kg) on CSAR-induced changes in activity of NTS barosensitive neurons. Bilateral NTS microinjection of losartan significantly attenuated the increases in arterial pressure, heart rate, and RSNA evoked by capsaicin, but also markedly (P<0.01) reversed the CSAR-induced blunted baroreflex control of RSNA (Gain max from 1.65 ± 0.10 to 2.22 ± 0.11 %/mmHg). In 17 of 24 (70.8 %) NTS barosensitive neurons, CSAR activation significantly (P<0.01) inhibited the baseline neuronal activity and attenuated the neuronal barosensitivity. In 11 NTS barosensitive neurons, intravenous losartan effectively (P<0.01) normalized the decreased neuronal barosensitivity induced by CSAR activation. In conclusion, blockade of NTS AT 1 receptors improved the blunted baroreflex during CSAR activation, suggesting that the NTS plays an important role in processing the interaction between the baroreflex and the Page 2 of 39 3 CSAR via an AT 1 receptor dependent mechanism.
and are activated by metabolic mediators, myocardial ischemia and cardiac enlargement (18) (19) (20) . The studies from this laboratory have shown that electrical and chemical stimulation of the CSAR markedly attenuates baroreflex function in normal and heart failure animals (8; 11; 34; 35) . Furthermore, the central angiotensin II (Ang II) mechanism has been reported to mediate the interaction between the CSAR and the baro reflex because intracerebroventricular injection of the Ang II type 1 (AT 1 ) receptor antagonist losartan normalizes the depression of baroreflex function evoked by CSAR activation (8; 9; 38; 39) . However, the exact region(s) in the central nervous system responsible for this interaction remain unclear.
The nucleus tractus solitarius (NTS) receives sensory inputs from a vast array of peripheral receptors located on viscera, somatic and cardiorespiratory organs and would be an effective region for modulating cardiovascular reflexes (1; 29) . The NTS is known to be the central termination site of baroreceptors and plays a critical role in integrating the baroreflex (29; 30) . On the other hand, axonal tracing studies have shown cardiac Page 4 of 39 sympathetic afferents project to the dorsal horn of the upper thoracic spinal cord through the stellate ganglia and the sympathetic chain (6; 13) . The ascending fibers from the dorsal horn of the spinal cord have been demonstrated to terminate in the NTS (22).
Electrophysiological evidence also suggests a subgroup of the NTS neurons can be excited by stimulation of cardiac sympathetic afferents (31) . Therefore, the NTS has been implicated to be an important area for integrating the central transmission of the CSAR (15; 31) .
Although at least two Ang II receptor subtypes, AT 1 and AT 2 , are expressed in rat brain, competition binding studies suggest that only AT 1 receptors are found in the NTS (28; 32) .
It has been suggested that an NTS-Ang II mechanism plays an important role in controlling cardiovascular activity (2; 37) . Microinjection of Ang II into the NTS has been found to modify AP and depress baroreflex function, whereas injection of Ang II receptor antagonists facilitates the baroreflex (4; 21). However, no evidence is available to address the question of whether an Ang II mechanism contributes to the interaction between the baroreflex and the CSAR at the level of the NTS.
Hence, the present study was designed to test the role of an NTS-AT 1 receptor mechanism in processing of the interaction between the CSAR and the baroreflex in anesthetized rats. We investigated the effects of bilateral microinjection of losartan into the NTS on the blunted baroreflex evoked by CSAR activation. We further determined the effects of CSAR activation on the activity of NTS barosensitive neurons before and after treatment with intravenous injection of losartan. 
MATERIALS AND METHODS

Animal preparation
All experiments were performed on adult male Sprague-Dawley rats weighing between 3 10-360 g and were approved by the Institutional Animal Care and Use Committee of the University of Nebraska Medical Center and were carried out under the guidelines of the American Physiological Society and the National Institutes of Health Guide of the Care and Use of Laboratory Animals. The methods for general surgery, RSNA recording, CSAR activation, and baroreflex measurement were described previously from our studies (8; 9).
General surgery
Rats were anesthetized with urethane (800 mg/kg ip) and -chloralose (40 mg/kg, ip).
The trachea was cannulated, and the rats was paralyzed with pancuronium bromide (1 mg/kg iv, 0.1 mg/kg thereafter as needed) and ventilated artificially with room air supplemented 100 % oxygen. The left common carotid artery was cannulated, and the AP was measured with a pressure transducer (Model PT300, Grass Instruments, Quincy, MA) for measurement of mean arterial pressure (MAP). HR was derived from the AP pulse using a Powerlab model 16S (ADinstruments, Colorado Spring, CO). The femoral vein was cannulated for intravenous injections. Rats were placed in a stereotaxic frame (Stoelting, Chicago, IL) and the dorsal surface of the medulla was surgically exposed by incising the atlantooccipital membrane and removing part of the occipital bone and dura.
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Supplemental doses of -chloralose (20 mg/kg, iv) were administered to maintain an appropriate level of anesthesia. Body temperature was maintained at about 37°C by an animal temperature controller (ATC1000, World Precision Instruments).
Recording of RSNA.
The left renal sympathetic nerves were exposed, identified and dissected free of the surrounding connective tissue, and placed on a pair of platinum-iridium recording electrodes. Both the nerve and the electrodes were covered with a fast setting silicone (Wacker Sil-Gel). The signal was amplified (band pass 100-1000 Hz) with a preamplifier (Model P 18D,Grass Instruments). The amplified discharge was monitored on a storage oscilloscope (Model 121 N, Tektronix, Beaverton, OR), imported to a computer system with other parameters, and then stored on disk until analyzed. Respective noise levels were subtracted from the nerve recording data before percentage changes from baseline were calculated. Integrated RSNA was normalized as 100 % baseline in the control period (15) .
Activation of the CSAR and the baroreceptors
Epicardial application of capsaicin has been demonstrated to effectively stimulate the cardiac sympathetic afferents (9; 39). The chest was opened through the fourth intercostal space. The pericardium was removed to expose the left ventricle. A filter paper containing capsaicin (3×3 mm, 0.4 µg in 2 µl) was applied to the anterior surface of the left ventricle. The baroreflex was tested about 2 min after capsaicin was applied, and then the epicardium was rinsed three times with 10 ml of warm normal saline (38 °C) .
The time interval of repeated capsaicin was at least 30 min in order to allow the AP, HR, RSNA, and discharge of NTS neurons to return to and stabilize at their control levels.
In order to test and evaluate the barosensitivity of NTS neurons in neuronal recording experiments, a vascular occluder (Harvard Apparatus) was placed around the descending thoracic aorta above the diaphragm and was used to elevate AP by constricting the aorta. 
Microinjections into the NTS
Extracellular recording of the NTS neurons
Single-unit extracellular recording was obtained using a single-micropipette (tip diameter 1-2 µm) (resistance 5-12 M ) filled with 0.5 M sodium acetate dissolved in 2 % Pontamine sky blue. The electrode was advanced using a microdrive (HSE-HA 864/1) into the dorsal medial NTS at a speed of 1-2 µm/s until single-unit activity was recorded.
The spontaneous action potentials were amplified using a high impedance preamplifier (Dagan Co.; band pass: 100-3000 Hz), fed into a window discriminator (Mentor N-750.
Spike Analyzer) which generates a standard pulse for each spike. Potentials were visualized on an oscilloscope (Model 121N, Tektronix, Beaverton, OR). The pulse output of the discriminator was then fed into a rate/interval monitor (HFC) whose analog output is proportional to the number of spikes per unit time (1 s). These signals were displayed online on the computer and recorded on the data acquisition system.
The barosensitivity of NTS neurons was identified by their excitatory response to transient AP elevation (20-50 mmHg) by aorta occlusion (5-10 s). Baroreceptor stimulation by aorta occlusion or balloon inflation has been performed to conveniently identify the barosensitivity of neurons in the brainstem (7; 16). Some specific NTS barosensitive neurons that were inhibited by aorta occlusion were not further observed in the present study. After a neuron of interest was recorded, a small amount of 2% Pontamine sky blue was iontophoresed (-15 µA, 10 min) to mark the recording location for histological analysis.
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Histological analysis
At the end of the experiment, the rat was given a lethal injection of pentobarbital (100 mg/kg, iv) and perfused with 10% formaldehyde solution (100 ml) intracardially. The brain stem was then quickly removed and fixed in 10% buffered Formalin. Frozen 50-µm coronal sections were made on a freezing microtome and mounted on slides. The dye spot and spread area for injection or cell recording sites were identified and plotted on standardized sections according to the atlas of Paxinos and Watson (24) . Data were excluded if the injection or recording sites were not located in the medial NTS area.
Figure1 shows the locations of the microinjection sites (A) and the recorded neurons (B)
in the NTS. There was no clear difference in topographical distributions between barosensitive and non-barosensitive neurons within the NTS.
Construction of baroreflex curves and evaluation of barosensitivity of NTS neurons
Baroreflex curves were generated by measuring the RSNA responses to a decrease and an increase in AP by intravenous injection of either nitroglycerin (25 µg) or phenylephrine (10 µg). MAP was altered at a rate of 1-2 mmHg/s during these infusions.
Increases and decreases in MAP were carried out in random order. The MAP data were acquired every 2 s from the threshold to the saturation points. A sigmoid logistic function was fit to the data using a non-linear regression program (SigmaPlot version. 8.0, SPSS) run on a computer. Four parameters were derived from the following equation. %RSNA =
the pressure at the mid point of the range (BP 50 ), and D is minimum RSNA. The peak slope [or maximum gain (Gain max )] was determined by taking the first derivative of the baroreflex curve described by equation.
The barosensitivity of NTS neurons was evaluated by percentage changes of baseline discharge during aorta occlusion. The magnitude of barosensitivity of NTS neurons in the control period was normalized as a barosensitivity of 100%. The barosensitivity was evaluated again after treatments at the same AP elevation used during the control test. Falls or increases in barosensitivity were expressed as percent reduction or elevation from the magnitude of barosensitivity in the control period.
Importantly, we also examined the change relationship between neuronal discharge and AP during aorta occlusion (spikes/mmHg) for further evaluating the barosensitivity.
Statistical analysis
The data are presented as the mean ± SEM. We constructed composite baroreflex curves by averaging the four parameters of the logistic equation for all curves and using the mean parameters to construct a single curve. The changes in integrated RSNA and neuronal activity after treatments were evaluated as percentage changes from control because of the variability in baseline RSNA in each animal and discharge in each neuron.
Comparisons between control and experimental interventions were made by either
Student's t-test (paired and unpaired) or one way analysis of variance. Differences were considered to be statistically significant when P<0.05.
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RESULTS
Effects of bilateral microinjection of losartan into the NTS on cardiovascular parameters in response to epicardial application of capsaicin
Table1 summarizes the cardiovascular parameters including AP, HR, RSNA, and the baroreflex before and 10 min after NTS injection of losartan (100 pmol each side) or aCSF (50 nl each side). NTS losartan markedly enhanced Gain max for baroreflex control of RSNA (from 1.98 ± 0.10 to 2.55 ± 0.15 %/mmHg, P<0.01, n=8) without altering baseline AP, HR, and RSNA. In control tests, NTS injection of 50 nl of aCSF (n = 5) did not alter any cardiovascular parameters. Figure 2 presents the baroreflex control of RSNA (MAP-RSNA curves) before and after NTS injection of losartan. As can be seen baroreflex sensitivity was increased following NTS losartan administration. The increases in AP, HR, and RSNA were significant and decrease in baroreflex sensitivity evoked by capsaicin were significantly (P<0.01) prevented 10 min after NTS losartan injection compared with NTS injection of aCSF (n=5) (Figures 4 and 5) . It was further demonstrated that, 10 min after NTS losartan, the baroreflex sensitivity during capsaicin completely recovered to the control level (Gain max : 2.22 ± 0.11 vs. 2.55 ± 0.15 %/mmHg, P>0.05) (Table1 and Figure 5B ).
Effects of epicardial application of capsaicin on activity of NTS neurons
A total of 53 spontaneously discharging neurons within the NTS were recorded from 28 rats in this study. Thirty five of 53 units were functionally identified as barosensitive neurons because they were rapidly excited by 110. In addition, we also tested the response of non-barosensitive NTS neurons to epicardial capsaicin. Interestingly it was found that, of 18 non-barosensitive neurons in response to capsaicin, 10 (56 %) were excited by an average of 71.8%, 3 (16 %) were inhibited by an average of 48.3 %, and 5 (28 %) did not respond.
Effects of intravenous losartan on the NTS neuronal barosensiti vity in response to epicardial application of capsaicin
Eleven barosensitive NTS neurons from 11 rats, which were sensitive to capsaicin, were tested in this experiment. Figure 8 shows the responses of neuronal barosensitivity to epicardial application of capsaicin 10 min after intravenous losartan (2 mg/kg in 0.3 ml normal saline). It was found that intravenous injection of losartan significantly decreased AP (from 96 ± 2 to 82 ± 3 mmHg, P<0.01) and HR (from 368 ± 7 to 332 ± 7 beats/min, P<0.01), whereas it increased ongoing activity of barosensitive neurons by 30.1 % (from Page 14 of 39 15 6.0 ± 1.2 to 7.5 ± 1.4 spikes/s, P<0.05). The neuronal barosensiti vity was increased to 119 ± 9 % ( discharge/ AP: from 0.124 ± 0.018 to 0.159 ± 0.011 spikes/mmHg, P<0.05) 7 min after intravenous losartan. Ten min after losartan, capsaicin did not significantly decrease the baseline discharge (7.3 ± 1.3 vs. 6.4 ± 1.1 spikes/s, P>0.05) or barosensitivity ( discharge/ AP: 0.159 ± 0.011 vs. 0.144 ± 0.014 spikes/mmHg, P>0.05).
We also noted that the baseline AP and neuronal discharge between 7 and 10 min after losartan were similar. The magnitudes of percent changes in discharge and barosensitivity of NTS neurons during capsaicin application before and after intravenously injected losartan are shown in Figure 8B . In addition, intravenous normal saline (0.3 ml, n=3) did not modify capsaicin-induced inhibition of NTS neurons (data not shown).
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DISCUSSION
Two important observations were made from the present study: 1) In the NTS, local blockade of AT 1 receptors attenuated the increased sympathetic activity and the blunted baroreflex evoked by CSAR activation; and 2) at the level of the NTS barosensitive neuron, CSAR activation produced a reduction of both baseline discharge and barosensitivity, which was effectively abolished by systemic losartan. The current data suggested that endogenous Ang II acting at AT 1 receptors in the NTS plays an important role in mediating the interaction between the baroreflex and the CSAR.
In chronic heart failure, the CSAR has been reported to be augmented and its enhancement may be one important factor which contributes to sympathetic hyperactivity and baroreflex impairment (8; 9; 33-35) . The current data also showed that, in normal rats, chemical activation of the CSAR by application of capsaicin to the left ventricle produced a sympathoexcitation and a reduction in baroreflex control of RSNA, which was consistent with the previous studies (8; 9; 34) . Consistent with our previous study (9) , we returned to their control values, which indicates that at this time that the effects of capsaicin had dissipated. Although we also have observed a significant attenuation of baroreflex sensitivity about 2 min after capsaicin treatment, the observed effects on the baroreflex may be less than those which would have occurred at an earlier time. To address the question of the central mechanism responsible for interaction between the CSAR and the baroreflex, there are at least two essential factors to understand. These are to identify the integrative region(s) in the brain and the neurotransmitters/receptors that participate in this interaction. Because the NTS receives convergent inputs from baroreceptor afferents and cardiac sympathetic afferents(22; 31) and the NTS Ang II mechanism participates in integrating the baroreflex (4; 5), we chose the NTS as the target region where the interaction between the CSAR and the baroreflex may occur.
The present results from the microinjection experiments showed that AT 1 receptor blockade in the NTS significantly increased the baroreflex function without modifying baseline AP, HR, and RSNA. This observation is consistent with previous studies from other laboratories (5; 21). These data suggest that endogenous Ang II acting on the NTS AT 1 receptors modifies baroreflex function. Importantly, we also found that AT 1 receptor blockade in the NTS significantly attenuated the increases in AP, HR, and RSNA evoked by capsaicin, and also effectively reversed the attenuation of the baroreflex by capsaicin.
We also observed that the capsaicin-induced barosensitivity after NTS losartan not only was reversed to the pre-injection level but was also enhanced ( Figure 5B ). Therefore, we believe that NTS losartan abolishes capsaicin-induced depression of baroreflex function, as well as increasing baroreflex sensitivity. These data strongly indicated that the functional states of the NTS AT 1 receptors are very important in mediating both the central transmission of the CSAR and the interaction between the CSAR and the baroreflex. The present data suggests that, during CSAR activation, endogenous Ang II release and acting on NTS AT 1 receptors results in an increase in sympathetic outflow and attenuation of the baroreflex. However, no direct evidence is available to demonstrate that, at the NTS level, release of Ang II is increased and the function of AT 1 receptors is up-regulated when the CSAR is activated. Importantly, previous data supports this idea. For instance, 1) angiotensin-converting enzyme mRNA expression within the NTS is higher in heart failure rats (27) ; 2) AT 1 receptor density in the NTS is up-regulated in a rabbit with heart failure in a radio-autographic study (40) . Although the CSAR is significantly augmented in heart failure (33; 34), contribution of the CSAR enhancement to increased Ang II or up-regulated AT 1 receptors in the NTS has not been confirmed and awaits further study. In addition to the NTS, other cardiovascular centers such as the rostral ventrolateral medulla (RVLM) and the paraventricular nucleus might also participate in this interaction (16; 38) .
In order to further elucidate the role of NTS-AT 1 mechanism in this interaction, we directly observed the effect of CSAR activation on NTS barosensitive neurons. In this work, we did not electrically stimulate the aortic or carotid sinus nerve to identify NTS neurons receiving baroreceptor afferents, and clearly this may be considered a limitation.
We believe that AP elevation by aorta occlusion may be similar to AP elevation by intravenous injection of phenylephrine, which has been shown to activate NTS neurons that are driven by single-pulse stimulation of the aortic nerve (26) . In the present study, an average of about 35 mmHg of AP elevation during aorta occlusion was verified to effectively stimulate the baroreceptors and activate the baroreflex ( Figure 6A ). Moreover, we also found that, in some tested NTS neurons, there exists a significantly positive correlation (r = 0.76, data not shown) between the change in AP by aorta occlusion and the firing rate of NTS neurons. In addition, a large change in AP (> 50 mmHg) while recording single units often results in the loss of the recording because the distance between the stationary microelectrode and the neuron of interest increased.
At the level of NTS barosensitive neurons, CSAR activation inhibited the basal discharge rate and attenuated the barosensitivity, which could be prevented by intravenous losartan. Losartan has been demonstrated to cross the blood-brain barrier in rats (17) . Because losartan is given intravenously in this work, its exact targets cannot be identified. However, some important observations from the current data indicate that endogenous Ang II acted at AT 1 receptors to mediate the CSAR-induced decreases in baseline discharge and barosensitivity of NTS neurons. We believe that the inhibitory effect of capsaicin on NTS neurons is not due to neuronal baroreflex activation because AP elevation by CSAR activation will produce an excitation of NTS barosensitive neurons.
It is well known that NTS barosensitive neurons , which receives input from the peripheral baroreceptors, excite the caudal ventrolateral medulla (CVLM) neurons via a glutamatergic projection, whereas the CVLM neurons inhibit the RVLM vasomotor Page 19 of 39 neurons via a GABAergic projection (1; 29) . The RVLM has been recognized as a critical site for generating sympathetic outflow and controlling baroreflex function (29) . Therefore, it is logical to assume that the inhibitory effect of CSAR activation on NTS barosensitive neurons would increase sympathetic outflow and that attenuation of the barosensitivity of NTS neurons would decrease the baroreflex function. Therefore, these new findings contribute to our understanding of the mechanism responsible for CSAR-induced sympathetic hyperactivity and baroreflex impairment. Because there are several pathways between the NTS and RVLM, we guess that reduction of barosensitive neurons by CSAR activation may not be a unique pathway (NTS-CVLM-RVLM pathway) to cause sympathoexcitation. More recently, we further find that CSAR activation significantly excites the chemosensitive neurons within the commissural NTS where neurons directly send the excitatory projection to the RVLM (36) . Therefore, in addition to inhibition of barosensitive neurons, excitation of chemosensitive neurons may be another important mechanism within the NTS to mediate the CSAR-induced sympathoexcitation. Taken together, we think that several mechanisms may simultaneously and together mediate the processing of CSAR-induced sympathoexcitation.
It has been reported that a neuron group exists within the NTS which can be excited by stimulation of cardiac sympathetic afferents and that excitatory amino acids may mediate this central transmission (15; 31) . Because these NTS neurons have not been further identified by barosensitivity, we assume these neurons directly receive cardiac sympathetic afferent input rather than baroreceptor input. Our results provide evidence Page 20 of 39 for this possibility because a majority (56%) of non-barosensitive neurons were excited by epicardial capsaicin. Therefore, it is possible that the CSAR-excitatory neurons are interneurons that release inhibitory neurotransmitters. CSAR-induced excitation of this inhibitory interneuron may produce an inhibition of NTS barosensitive neurons, which is consistent with CSAR activation resetting barosensitivity. There is substantial evidence that GABA may be the inhibitory neurotransmitter within the NTS. For example, iontophoretic application of GABA markedly reduced or abolished the responses of NTS neurons to stimulation of baroreceptors (3) . Inhibitory interneurons in the NTS has become a well accepted notion to explain baroreflex resetting (7; 25) .
In summary, blockade of AT 1 receptors significantly improved the depressed baroreflex function evoked by CSAR activation at the level of the NTS in anesthetized rats, suggesting that an NTS-Ang II mechanism plays an important role in processing the interaction between the baroreflex and the CSAR. However, because of the acute nature of the experiments in the present study, it is not known if the NTS-Ang II mechanism exists in more chronic pathological conditions such as chronic heart failure. 
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